SEC filing: Statement of changes in beneficial ownership of securities Share on Facebook Share on Facebook Share on LinkedIn Share on LinkedIn Share on X Share on X Share on Pinterest Share on Pinterest Share via email Share via email
investor press clippings science Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman Read more
press release investor science BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant Read more
investor press clippings World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer “eXoZymes represents a new generation of synthetic biology design and scale-up,” Perriman said. He... Read more
